Feagan BG - Search Results

1

Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.

Feagan BG, Sandborn WJ, Lazar A, Thakkar RB, Huang B, Reilly N, Chen N, Yang M, Skup M, Mulani P, Chao J. Feagan BG, et al. Gastroenterology. 2014 Jan;146(1):110-118.e3. doi: 10.1053/j.gastro.2013.09.032. Epub 2013 Sep 22. Gastroenterology. 2014. PMID: 24067881 Clinical Trial.

2

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF, Sutherland LR. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2002 Feb;122(2):512-30. doi: 10.1053/gast.2002.31072. Gastroenterology. 2002. PMID: 11832465 Review. No abstract available.

3

Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.

Steinhart AH, Feagan BG, Wong CJ, Vandervoort M, Mikolainis S, Croitoru K, Seidman E, Leddin DJ, Bitton A, Drouin E, Cohen A, Greenberg GR. Steinhart AH, et al. Among authors: feagan bg. Gastroenterology. 2002 Jul;123(1):33-40. doi: 10.1053/gast.2002.34225. Gastroenterology. 2002. PMID: 12105831 Clinical Trial.

4

Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?

Feagan BG, Sandborn WJ. Feagan BG, et al. Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15. Rev Gastroenterol Disord. 2002. PMID: 12478239 Review.

5

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.

Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2003 Aug;125(2):380-8. doi: 10.1016/s0016-5085(03)00877-1. Gastroenterology. 2003. PMID: 12891539 Clinical Trial.

6

The effects of infliximab maintenance therapy on health-related quality of life.

Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR. Feagan BG, et al. Am J Gastroenterol. 2003 Oct;98(10):2232-8. doi: 10.1111/j.1572-0241.2003.07674.x. Am J Gastroenterol. 2003. PMID: 14572573 Clinical Trial.

7

AGA technical review on perianal Crohn's disease.

Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB; American Gastroenterological Association Clinical Practice Committee. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2003 Nov;125(5):1508-30. doi: 10.1016/j.gastro.2003.08.025. Gastroenterology. 2003. PMID: 14598268 Review. No abstract available.

8

Maintenance therapy for inflammatory bowel disease.

Feagan BG. Feagan BG. Am J Gastroenterol. 2003 Dec;98(12 Suppl):S6-S17. doi: 10.1016/j.amjgastroenterol.2003.11.002. Am J Gastroenterol. 2003. PMID: 14697913 Review.

9

The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain.

Sandborn WJ, Feagan BG. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2004 Sep;127(3):990-3. doi: 10.1053/j.gastro.2004.07.037. Gastroenterology. 2004. PMID: 15362055 No abstract available.

10

Unemployment and disability in patients with moderately to severely active Crohn's disease.

Feagan BG, Bala M, Yan S, Olson A, Hanauer S. Feagan BG, et al. J Clin Gastroenterol. 2005 May-Jun;39(5):390-5. doi: 10.1097/01.mcg.0000159220.70290.41. J Clin Gastroenterol. 2005. PMID: 15815207 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters